Role of the Receptor Tyrosine Kinase Axl and its Targeting in Cancer Cells

By  

Current Medicinal Chemistry, Vol. 23, Iss. 15, 2016-05 ,pp. : 1496-1512

Bentham Science Publishers

Access to resources Recommend Favorite

Phase I trial of orally administered CEP-701, a novel neurotrophin receptor-linked tyrosine kinase inhibitor

By Marshall John L.   Kindler Hedy   Deeken John   Bhargava Pankaj   Vogelzang Nicholas J.   Rizvi Naiyer   Luhtala Taina   Boylan Stacy   Dordal Margaret   Robertson Philmore   Hawkins Michael J.   Ratain Mark J.  

Investigational New Drugs, Vol. 23, Iss. 1, 2005-01 ,pp. : 31-37

Springer Publishing Company

Access to resources Recommend Favorite

Relationship between Cellular Apoptosis and the Expression of p75 Neurotrophin Receptor and Tyrosine Kinase A Receptor in Tissue Surrounding Haematoma in Intracerebral Haemorrhage

By Bao G   Han Y   Wang M   Xu G  

The Journal of International Medical Research, Vol. 39, Iss. 1, 2011-01 ,pp. : 150-160

Field House Publishing

Access to resources Recommend Favorite

Flt3 Receptor Tyrosine Kinase as a Drug Target in Leukemia

By  

Current Pharmaceutical Design, Vol. 10, Iss. 16, 2004-06 ,pp. : 1867-1883

Bentham Science Publishers

Access to resources Recommend Favorite

Oral Targeting of Protein Kinase C Receptor: Promising Route for Diabetic Retinopathy?

By  

Current Drug Delivery, Vol. 9, Iss. 4, 2012-07 ,pp. : 405-413

Bentham Science Publishers

Access to resources Recommend Favorite